Are the adult and children's versions of Astepro (azelastine) different?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Are Adult and Children's Astepro Different?

No, adult and children's Astepro (azelastine) formulations use the same concentration and medication, but the dosing differs based on age and weight. The product itself is identical; what changes is how much you spray and how often, depending on the patient's age group.

Formulation Details

  • Astepro 0.15% solution contains 205.5 µg of azelastine per spray and is approved for both seasonal and perennial allergic rhinitis in patients 6 years and older 1
  • The medication formulation is the same bottle and concentration for all age groups—there is no separate "children's version" with different ingredients or lower concentration 1
  • The 0.15% formulation includes sorbitol and sucralose additives to improve taste, which is particularly important given that bitter taste affects 4.5-19.7% of patients 2, 3

Age-Based Dosing Differences

Children 6-11 Years

  • 1 spray per nostril twice daily 1, 4, 2
  • This lower frequency reflects appropriate dosing for smaller body size and developing physiology

Adolescents and Adults ≥12 Years

  • 1-2 sprays per nostril twice daily, OR 2 sprays per nostril once daily 1, 4, 2
  • Greater dosing flexibility allows for symptom severity adjustment and patient preference

Important Age Restriction

  • Azelastine is NOT approved for children younger than 6 years 1, 4, 2
  • This exclusion exists due to lack of safety and efficacy data in younger children, not because a different formulation is needed

Clinical Implications

  • The same bottle can be prescribed across age groups—you simply instruct patients on the appropriate number of sprays based on age 1
  • Pharmacokinetic studies show that topical intranasal delivery provides targeted local effects with limited systemic absorption, making age-based dosing adjustments primarily about efficacy rather than safety concerns 5, 3
  • Common pitfall: Prescribers sometimes assume they need to order a "pediatric formulation," but this does not exist—simply adjust the dosing instructions 1

Side Effect Profile Across Ages

  • Somnolence occurs in 0.9-11.5% of patients regardless of age, though proper administration technique (avoiding post-nasal drip into throat) can minimize this 2, 3
  • Bitter taste remains the most common complaint across all age groups at 4.5-19.7% 2, 3
  • Headache and epistaxis occur at similar rates in children and adults 1, 2

Practical Prescribing Approach

For children 6-11 years: Write "Astepro 0.15%: 1 spray each nostril twice daily" 1, 2

For patients ≥12 years: Write "Astepro 0.15%: 1-2 sprays each nostril twice daily OR 2 sprays each nostril once daily" based on symptom severity and patient preference 1, 2

The key takeaway is that you're using the identical medication bottle with age-appropriate dosing instructions—there is no separate pediatric product to stock or prescribe 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Azelastine Nasal Spray Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Combination Therapy for Allergic Rhinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.